GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
3.680
-0.220 (-5.64%)
At close: May 24, 2024, 4:00 PM
3.730
+0.050 (1.36%)
After-hours: May 24, 2024, 7:55 PM EDT

GT Biopharma Stock Forecast

GTBP's stock price has decreased by -58.97% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for GT Biopharma stock have an average target of 105, with a low estimate of 60 and a high estimate of 150. The average target predicts an increase of 2,753.26% from the current stock price of 3.68.

Analyst Consensus: Buy
Target Low Average Median High
Price $60 $105 $150 $150
Change +1530.4% +2753.3% +3976.1% +3976.1%
* Price targets were last updated on Aug 8, 2023.

Analyst Ratings

The average analyst rating for GT Biopharma stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 111111
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong Buy Reiterates $150 +3,976.09% Aug 8, 2023
EF Hutton
EF Hutton
Hold
Reiterates
$60
Hold Reiterates $60 +1,530.43% Aug 7, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong Buy Reiterates $150 +3,976.09% Jun 5, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong Buy Reiterates $150 +3,976.09% May 17, 2023
EF Hutton
EF Hutton
Hold
Reiterates
$60
Hold Reiterates $60 +1,530.43% May 16, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-11.02
from -5.64
EPS Next Year
-0.72
from -11.02
Year 2019202020212022202320242025
Revenue
-------
Revenue Growth
-------
EPS
-0.30-193.50-61.80-19.66-5.64-11.02-0.72
EPS Growth
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 20242025
High -11.34 -0.75
Avg -11.02 -0.72
Low -10.58 -0.70

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.